Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

FERROUS GLUCONATE CRS (50 MG)

FERROUS GLUCONATE CRS (50 MG)

299-29-6

DISCOVER
FLECAINIDE ACETATE CRS (10 MG)

FLECAINIDE ACETATE CRS (10 MG)

54143-56-5

DISCOVER
FLECAINIDE IMPURITY A CRS (20MG)

FLECAINIDE IMPURITY A CRS (20MG)

NA

DISCOVER
FLECAINIDE IMPURITY B CRS (70MG)

FLECAINIDE IMPURITY B CRS (70MG)

NA

DISCOVER
FLUCLOXACILLIN SODIUM CRS (250 MG)

FLUCLOXACILLIN SODIUM CRS (250 MG)

1847-24-1

DISCOVER
FLUCYTOSINE CRS (50 MG)

FLUCYTOSINE CRS (50 MG)

2022-85-7

DISCOVER
FLUDROCORTISONE ACETATE CRS (100 MG)

FLUDROCORTISONE ACETATE CRS (100 MG)

514-36-3

DISCOVER
FLUMAZENIL - REFERENCE SPECTRUM (N/A)

FLUMAZENIL - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
FLUMETASONE PIVALATE CRS (100MG)

FLUMETASONE PIVALATE CRS (100MG)

2002-29-1

DISCOVER
FLUMEQUINE CRS (60 MG)

FLUMEQUINE CRS (60 MG)

42835-25-6

DISCOVER
FLUMEQUINE IMPURITY B CRS (0.1 MG)

FLUMEQUINE IMPURITY B CRS (0.1 MG)

NA

DISCOVER
FLUNARIZINE DIHYDROCHLORIDE CRS (50 MG)

FLUNARIZINE DIHYDROCHLORIDE CRS (50 MG)

30484-77-6

DISCOVER